Breast cancer detection by analyzing the volatile organic compound (VOC) signature in human urine
[ad_1]
US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann. Intern. Med. 151(10), 716–236 (2009).
Nelson, H. D. et al. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann. Intern. Med. 151(10), 727–737 (2009).
Center for Disease Control (CDC). Health, United States, 2019, Table 33.
Feldstein, A. C. et al. Patient barriers to mammography identified during a reminder program. J. Womens Health 20(3), 421–428 (2011).
Jemal, Ahmedin, Ward, Elizabeth & Thun, Michael J. Recent trends in breast cancer incidence rates by age and tumor characteristics among US women. Breast Cancer Res. 9(3), 1–6 (2007).
Broeders, M. et al. The impact of mammographic screening on breast cancer mortality in Europe: A review of observational studies. J. Med. Screen. 19(1 suppl), 14–25 (2012).
Blumen, H., Fitch, K. & Polkus, V. Comparison of treatment costs for breast cancer, by tumor stage and type of service. Am. Health Drug Benefits 9(1), 23 (2016).
Barlow, W. E. et al. Accuracy of screening mammography interpretation by characteristics of radiologists. J. Natl Cancer Inst. 96(24), 1840–1850 (2004).
Desreux, J. A. Breast cancer screening in young women. Eur. J. Obstetr. Gynecol. Reprod. Biol. 230, 208–211 (2018).
Siu, A. L. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann. Intern. Med. 164(4), 279–296 (2016).
Sechopoulos, I., Suryanarayanan, S., Vedantham, S., D’Orsi, C. J. & Karellas, A. Radiation dose to organs and tissues from mammography: Monte Carlo and phantom study. Radiology 246(2), 434–443 (2008).
Gøtzsche, P. C. The debate on breast cancer screening with mammography is important. J. Am. Coll. Radiol. 1(1), 8–14 (2004).
World Health Organization. WHO Position Paper on Mammography Screening (WHO, 2014).
World Health Organization. Disease Burden and Mortality Estimates (WHO, 2018).
Apantaku, L. M. Breast cancer diagnosis and screening. Am. Fam. Phys. 62(3), 596–602 (2000).
Podgornova, Y. A. & Sadykov, S. S. Detection of malignant breast tumors on the background of fibrocystic breast disease. In CEUR Workshop Proceedings, Vol. 2210, 177 (2018).
Malherbe, K. & Fatima, S. Fibrocystic Breast Disease (2019).
Warner, E. et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292(11), 1317–1325 (2004).
Mango, V. L., Goel, A., Mema, E., Kwak, E. & Ha, R. Breast MRI screening for averagerisk women: A Monte Carlo simulation costbenefit analysis. J. Magn. Reson. Imaging 49(7), e216–e221 (2019).
Persaud, Krishna & Dodd, George. Analysis of discrimination mechanisms in the mammalian olfactory system using a model nose. Nature 299(5881), 352–355 (1982).
Asimakopoulos, A. D. et al. Prostate cancer diagnosis through electronic nose in the urine headspace setting: A pilot study. Prostate Cancer Prostatic Dis. 17(2), 206–211 (2014).
Guerrero-Flores, H. et al. A non-invasive tool for detecting cervical cancer odor by trainedscent dogs. BMC Cancer 17(1), 79 (2017).
Buszewski, B. et al. Identification of volatile lung cancer markers by gas chromatography-mass spectrometry: Comparison with discrimination by canines. Anal. Bioanal. Chem. 404(1), 141–146 (2012).
Blatt, R., Bonarini, A. & Matteuci, M. Pattern Classification Techniques for Lung Cancer Diagnosis by an Electronic Nose 397–423 (Springer, 2010).
Phillips, M. et al. Rapid point-of-care breath test for biomarkers of breast cancer and abnormal mammograms. PLoS ONE 9(3), e90226 (2014).
Burton, C. & Ma, Y. Current trends in cancer biomarker discovery using urinary metabolomics: Achievements and new challenges. Curr. Med. Chem. 24, 5–28 (2017).
Guo, C. et al. Discriminating patients with early-stage breast cancer from benign lesions by detection of oxidative DNA damage biomarker in urine. Oncotarget 8(32), 53100 (2017).
Horvath, G., Järverud, G., Järverud, S. & Horváth, I. Human ovarian carcinomas detected by specific odor. Integr. Cancer Ther. 7(2), 76–80 (2008).
Lavra, L. et al. Investigation of VOCs associated with different characteristics of breast cancer cells. Sci. Rep. 5(1), 13246 (2015).
van Keulen, K. E., Jansen, M. E., Schrauwen, R. W., Kolkman, J. J. & Siersema, P. D. Volatile organic compounds in breath can serve as a noninvasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer. Aliment. Pharmacol. Therap. 51(3), 334–346 (2020).
Antoce, A. O. & Namolosanu, I. O. A. N. Rapid and precise discrimination of wines by means of an electronic nose based on gas-chromatography. Rev. Chim. 62(6), 593–595 (2011).
Kishimoto, N. & Kashiwagi, A. Evaluation of filtration on volatile compounds in virgin olive oils using an electronic nose. In 2019 IEEE International Symposium on Olfaction and Electronic Nose (ISOEN), 1–3 (IEEE, 2019).
Dent, A., Sutedja, T. & Zimmerman, P. Exhaled breath analysis for lung cancer. J. Thorac. Dis. 63(2), 164–168 (2013).
Peng, G. et al. Detection of lung, breast, colorectal and prostate cancers from exhaled breath using a single array of nanosensors. Br. J. Cancer 103(4), 542–551 (2010).
Peled, N. et al. Non-invasive breath analysis of pulmonary nodules. J. Thorac. Oncol. 7(10), 1528–1533 (2012).
Di Natale, C. et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens. Bioelectron. 18(10), 1209–1218 (2003).
D’Amico, A. et al. An investigation on electronic nose diagnosis of lung cancer. Lung Cancer 68(2), 170–176 (2010).
Huang, Y., Li, Y., Luo, Z. & Duan, Y. Investigation of biomarkers for discriminating breast cancer cell lines from normal mammary cell lines based on VOCs analysis and metabolomics. R. Soc. Chem. Adv. 6(48), 41816–41824 (2016).
Wang, C. et al. Volatile organic metabolites identify patients with breast cancer, cyclomastopathy, and mammary gland fibroma. Sci. Rep. 4(1), 5383 (2014).
Silva, C., Perestrelo, R., Silva, P., Tomás, H. & Câmara, J. Volatile metabolomic signature of human breast cancer cell lines. Sci. Rep. 7, 43969 (2017).
Li, J. et al. Investigation of potential breath biomarkers for the early diagnosis of breast cancer using gas chromatography-mass spectrometry. Clin. Chim. Acta 436, 59–67 (2014).
Vignoli, A. et al. Precision oncology via NMR-based metabolomics: A review on breast cancer. Int. J. Mol. Sci. 22(9), 4687 (2021).
Weber, C. et al. Evaluation of a gas sensor array and pattern recognition for the identification of bladder cancer from urine headspace. Analyst 136(2), 359–364 (2011).
Roine, A. et al. Detection of smell print differences between nonmalignant and malignant prostate cells with an electronic nose. Future Oncol. 8(9), 1157–1165 (2012).
Watson, J. The tin oxide gas sensor and its applications. Sens. Actuators 5(1), 29–42 (1984).
Mazzone, P. et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax 62(7), 565–568 (2007).
Machado, R. et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am. J. Respir. Crit. Care Med. 171(11), 1286–1291 (2005).
Dragonieri, S. et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 64(2), 166–170 (2009).
O’Donovan, P. et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 309, 1871–1874 (2005).
Brooks, S., Moore, D., Marzouk, E., Glenn, F. & Hallock, R. Canine olfaction and electronic nose detection of volatile organic compounds in the detection of cancer: A review. Cancer Investig. 33(9), 411–419 (2015).
List of MAK and BAT Values 2017: Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area. Report 53, Vol. 17, 1st ed, 14–36 (WILEYVCH Verlag GmbH and Co. KGaA, 2017).
”The PubChem Project”. Pubchem.ncbi.nlm.nih.gov. https://pubchem.ncbi.nlm.nih.gov (2018) (Accessed 10 March 2018).
”Human Metabolome Database”, HMDB. http://www.hmdb.ca (2018) (Accessed 30 May 2018).
Mochalski, P. & Unterkofler, K. Quantification of selected volatile organic compounds in human urine by gas chromatography selective reagent ionization time of flight mass spectrometry (GC-SRI-TOF-MS) coupled with head-space solid-phase microextraction (HS-SPME). Analyst 141(15), 4796–4803 (2016).
Brsan, N. & Weimar, U. Understanding the fundamental principles of metal oxide based gas sensors; the example of CO sensing with SnO2 sensors in the presence of humidity. J. Phys. Condens. Matter 15(20), 813–839 (2003).
Henriksen, T., Hillestrom, P., Poulsen, H. & Weimann, A. Automated method for the direct analysis of 8-oxo-guanosine and 8-oxo-2’-deoxyguanosine in human urine using ultraperformance liquid chromatography and tandem mass spectrometry. Free Radic. Biol. Med. 47(5), 629–635 (2009).
Smith, S. et al. A comparative study of the analysis of human urine headspace using gas chromatography–mass spectrometry. J. Breath Res. 2, 037022 (2008).
Allen, B. et al. Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism. Redox Biol. 2, 963–970 (2014).
[ad_2]
Source link
